Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luke Canham
What Are the Participants’ Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded Within a Double-Blind RCT
Multiple Sclerosis International
Neurology
Related publications
A Double-Blind Controlled Trial of Long Chain N-3 Polyunsaturated Fatty Acids in the Treatment of Multiple Sclerosis.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Double Blind Study of Intrathecal Beta-Interferon in Multiple Sclerosis: Clinical and Laboratory Results.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Unblinding Following Trial Participation: Qualitative Study of Participants’ Perspectives
Clinical Trials
Medicine
Pharmacology
Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study
Journal of Affective Disorders
Psychiatry
Clinical Psychology
Mental Health
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
A New Biotherapeutic Approach for the Treatment of Multiple Sclerosis
Translational Medicine
Multiple Challenges for People After Transitioning to Secondary Progressive Multiple Sclerosis: A Qualitative Study
BMJ Open
Medicine
CUF, a Herbal Formula for the Treatment of Asthma: A Randomized, Double-Blind, Placebo-Controlled Study in the Treatment of Childhood Asthma
Health
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
The Lancet
Medicine
